HAILEY CHASTAIN: Open Payments
NPI 1184473894 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,748 in 145 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $1,266 · 2025 $2,748
Food & beverage: $2,748
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $300 |
| SK Life Science, Inc. | 13 | $286 |
| UCB, Inc. | 16 | $253 |
| Neurocrine BioSciences, Inc. | 8 | $235 |
| JAZZ PHARMACEUTICALS INC. | 10 | $207 |
| PFIZER INC. | 13 | $194 |
| Lilly USA, LLC | 9 | $161 |
| Janssen Biotech, Inc. | 5 | $156 |
| Biogen, Inc. | 5 | $109 |
| EMD Serono, Inc. | 5 | $94 |
Products named: INGREZZA, EPIDIOLEX, Briviact, KISUNLA, QULIPTA, NURTEC ODT, UBRELVY, Symbravo.
Industry payments across AL — which companies pay providers there.
